herp
simplex
strain
f
gene
bank
kindli
provid
dr
kawaguchi
univers
tokyo
tokyo
japan
hek
vero
cell
cultur
dmem
nacalai
kyoto
japan
supplement
fc
hyclon
logan
ut
usa
uml
penicillin
streptomycin
nacalai
target
plasmid
system
construct
introduc
synthes
primer
correspond
target
sequenc
bbsi
restrict
site
plasmid
addgen
cambridg
usa
guid
sequenc
select
identifi
bp
sequenc
directli
upstream
sequenc
either
ge
tk
gene
twenti
nucleotid
guid
sequenc
ge
tk
contain
fewer
nucleotid
match
unrel
genom
sequenc
select
addit
guanin
cytosin
append
sens
primer
directli
end
target
sequenc
allow
guanin
first
base
transcript
human
clone
pcineo
express
plasmid
promega
madison
wi
usa
plasmid
ssodn
transfect
cell
use
pei
max
polysci
warrington
pa
usa
human
embryon
kidney
cell
cultur
densiti
cellsdish
mm
dish
ml
dmem
contain
fc
transfect
reagent
prepar
describ
gener
mutant
virus
mock
target
construct
dilut
ml
life
technolog
carlsbad
ca
usa
gener
revert
virus
pair
target
construct
ssodn
contain
sequenc
repair
dilut
ml
dilut
plasmid
mix
pei
dilut
ml
min
room
temperatur
thereaft
plasmid
pei
mixtur
ad
hek
cell
cultur
day
transfect
mix
microbead
label
monoclon
antibodi
mab
miltenyi
biotech
bergisch
gladbach
germani
cell
isol
use
automac
mac
ls
column
miltenyi
infect
hr
infect
supernat
replac
fresh
dmem
contain
fc
remov
origin
virus
time
ssodn
contain
sequenc
repair
retransfect
use
pei
gener
revert
virus
day
cultur
supernat
expect
contain
mutat
virus
serial
dilut
mix
vero
cell
cellswel
tissu
cultur
plate
kept
day
cell
surfac
phenotyp
vero
cell
infect
recombin
virus
analyz
flow
cytometri
cell
obtain
cultur
infect
cell
presenc
acv
ge
tk
gene
amplifi
cultur
supernat
infect
cell
sequenc
ssodn
bear
ge
sequenc
nt
design
gener
revert
viru
gener
viru
carri
ge
nt
ssodn
contain
sequenc
ge
signal
sequenc
extracellular
domain
ge
use
silent
mutat
italic
includ
ssodn
sequenc
would
recogn
construct
cell
incub
mab
clone
santa
cruz
biotechnolog
santa
cruz
ca
usa
mab
clone
oghi
mbl
nagoya
japan
well
mab
clone
follow
alexa
mab
life
technolog
mab
clone
establish
immun
gb
fragment
amino
acid
residu
fuse
human
fc
region
use
titermax
gold
adjuv
cytrx
lo
angel
ca
usa
accord
manufactur
instruct
mab
produc
b
cell
hybridoma
gener
use
previous
describ
method
express
ge
gb
assess
use
flow
cytomet
facscalibur
bd
bioscienc
franklin
lake
nj
usa
ge
tk
orf
flank
untransl
region
amplifi
pcr
cultur
supernat
vero
cell
infect
mutat
use
kod
fx
dna
polymeras
toyobo
osaka
japan
primer
pair
ge
sens
tk
sens
accord
manufactur
instruct
purif
amplifi
dna
use
wizard
sv
gel
pcr
system
promega
ge
tk
dna
sequenc
determin
use
genet
analyz
appli
biosystem
waltham
usa
herp
simplex
viru
contain
larg
dna
genom
kbp
ge
function
fc
receptor
host
immunoglobulin
form
heterodim
gi
determin
whether
system
could
use
edit
viral
genom
first
attempt
made
edit
ge
gene
design
three
uniqu
nt
guid
sequenc
follow
pam
sequenc
orf
ge
fig
clone
pyogen
chimer
sgrna
construct
transfect
hek
cell
along
plasmid
express
human
marker
transfect
posit
cell
transfect
enrich
infect
high
proport
cell
cell
observ
transfect
fig
proport
cell
cell
quit
low
cell
transfect
enrich
posit
cell
therefor
enrich
cell
use
cell
surfac
marker
increas
effici
genom
edit
order
isol
clone
target
system
cultur
supernat
contain
produc
transfect
sequenti
dilut
inocul
onto
vero
cell
tissu
cultur
plate
well
contain
vero
cell
monoclon
infect
identifi
microscopi
genom
around
ge
gene
amplifi
pcr
cultur
supernat
infect
cell
thereaft
ge
gene
sequenc
determin
fig
mutat
ge
gene
detect
clone
obtain
transfect
three
plasmid
mock
plasmid
fig
particular
clone
contain
expect
mutat
ge
target
sequenc
use
cell
infect
virus
possess
frameshift
mutat
express
ge
surfac
fig
hand
cell
infect
clone
carri
mutat
ge
still
express
ge
surfac
fig
f
express
ge
cell
infect
clone
assess
flow
cytometri
ge
gene
clone
lack
ge
express
cell
surfac
sequenc
almost
clone
found
contain
expect
ge
mutat
fig
f
next
anoth
gene
tk
respons
suscept
acv
one
drug
use
treat
hsv
viru
infect
examin
acv
phosphoryl
viral
tk
cellular
tk
phosphoryl
acv
competit
inhibit
viral
dna
polymeras
deoxyguanosin
triphosph
result
inhibit
viral
replic
virus
also
gener
use
system
procedur
use
gener
virus
fig
b
mani
mutant
obtain
cell
transfect
construct
wherea
one
clone
obtain
cell
transfect
construct
fig
almost
half
clone
obtain
cell
transfect
construct
contain
expect
mutat
tk
gene
construct
target
use
clone
contain
delet
tk
gene
resist
acv
region
amino
acid
residu
tk
highli
conserv
among
hsv
involv
nucleotid
bind
homodimer
tk
delet
region
might
significantli
affect
function
tk
furthermor
clone
found
contain
mutat
tk
gene
acv
select
fig
contrast
one
clone
obtain
cell
transfect
construct
mutat
tk
gene
relat
target
site
attempt
made
gener
virus
use
system
fig
pair
construct
target
flank
region
mutat
site
ssodn
bear
ge
sequenc
repair
templat
plasmid
cotransfect
hek
cell
silent
mutat
includ
repair
ssodn
sequenc
would
recogn
construct
two
day
later
express
cell
isol
infect
virus
mutant
fig
f
product
clone
evalu
use
flow
cytometri
assess
express
ge
cell
surfac
well
sequenc
ge
gene
clone
fig
b
revert
express
ge
silent
mutat
detect
clone
possess
ge
identifi
fig
revert
obtain
repair
ssodn
transfect
without
pair
target
plasmid
gener
revert
virus
less
effici
virus
carri
simpl
ge
mutat
fig
e
virus
fail
incorpor
repair
ssodn
addit
muation
ge
gener
pair
plasmid
ge
gene
sequenc
around
target
site
five
revert
clone
gener
pair
plasmid
target
ge
ge
along
ssodn
ident
also
ident
ge
sequenc
obtain
two
revert
clone
gener
plasmid
pair
target
ge
ge
five
clone
plasmid
target
ge
ge
ge
sequenc
outsid
target
site
remain
ident
parent
sequenc
fig
genom
dna
delet
pair
seemingli
repair
effici
ssodn
undelet
parent
genom
dna
mutant
virus
express
ge
gener
use
procedur
similar
use
gener
virus
pair
construct
design
target
flank
region
signal
sequenc
cleavag
site
ssodn
pair
construct
design
includ
downstream
ge
signal
sequenc
fig
vero
cell
infect
ge
mutant
gener
techniqu
express
surfac
fig
c
upper
panel
sequenc
ge
gene
amplifi
pcr
cultur
supernat
express
cell
confirm
insert
within
ge
gene
sequenc
design
fig
overal
product
frequenc
virus
approxim
fig
lower
panel
studi
exploit
system
edit
larg
kb
genom
procedur
enabl
us
gener
specif
gene
mutat
high
frequenc
less
week
fig
clone
gener
system
expect
mutat
appropri
target
sequenc
use
high
effici
genom
edit
system
could
obtain
specif
mutant
appar
without
unexpect
mutat
howev
target
plasmid
highli
effici
genom
edit
inde
effici
plasmid
target
ge
tk
respect
use
effici
edit
viral
genom
seem
affect
target
sequenc
use
certain
phenotyp
chang
induc
mutat
enhanc
effici
shown
mutat
ge
tk
inde
almost
viral
clone
expect
mutat
mutant
virus
phenotyp
enrich
ge
express
acv
sensit
therefor
gener
mutant
use
system
much
effici
use
convent
method
mutant
virus
gener
spontan
homolog
recombin
presenc
extrins
introduc
gene
although
edit
essenti
gene
involv
viral
surviv
infect
may
possibl
edit
essenti
gene
use
hek
cell
vero
cell
transfect
gene
interest
although
undesir
mutat
concern
system
mutat
might
decreas
use
mutat
nucleas
caus
break
introduc
nick
use
mutant
might
use
decreas
effect
viral
genom
edit
recent
engin
gene
adenoviru
system
report
howev
current
studi
gener
viru
also
revert
viru
gene
viru
close
essenti
studi
specif
viral
gene
addit
assess
cell
infect
mutant
viru
flow
cytometri
directli
ascertain
effect
gene
edit
therefor
studi
provid
import
inform
requir
edit
viral
gene
system
use
system
enabl
us
rapidli
effici
gener
mutant
virus
without
construct
bac
plasmid
contain
viral
genom
addit
method
allow
function
analysi
viral
gene
directli
deriv
field
patient
detect
virus
approxim
randomli
chosen
clone
without
use
select
marker
system
use
introduc
genet
ablat
virus
also
gener
virus
system
reportedli
use
edit
hiv
genom
integr
host
cell
genom
howev
author
techniqu
differ
viral
dna
genom
directli
edit
system
mutant
candid
clinic
trial
oncolyt
virotherapi
edit
larg
viral
genom
use
system
could
contribut
gener
mutant
virus
suitabl
therapeut
applic
addit
system
appli
larg
dna
virus
belong
herpesvirida
poxvirida
baculovirida
famili
cytomegaloviru
viru
viru
vaccinia
viru
furthermor
techniqu
enabl
engin
virus
therapeut
usag
viral
vector
tumor
lysi
readili
convent
method
author
declar
compet
financi
interest
